Structure |
Chemical Name |
CAS |
MF |
 |
Valsartan related compound H |
|
|
 |
Vildagliptin Related Compound H |
2253194-13-5 |
C12H16N4O |
 |
Moxifloxacin Impurity 7 |
|
|
![(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one](/CAS/20180703/GIF/869478-12-6.gif) |
(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one |
869478-12-6 |
C17H15NO4 |
 |
Timolol Impurity 1 |
75014-25-4 |
C13H24N4O5S |
 |
Merariveron impurity D |
|
C26H28N6O3S2 |
 |
Cefazolin impurity E |
|
|
 |
Telmisartan EP-J |
885045-90-9 |
C33H29ClN4O2 |
 |
Lamivudine Impurity Mixture |
|
|
 |
Pitavastatin Impurity 29 |
148516-15-8 |
C25H20FNO2 |
 |
Rifaximin impurity B |
1351775-04-6 |
C43H49N3O11 |
 |
Rosuvastatin Related Compound 6 |
521973-99-9 |
C13H23ClO4 |
 |
Medetomidine impurity |
2250243-44-6 |
C20H22N2O |
 |
4-(3-(Piperidin-1-yl)propoxy)benzoic acid |
767286-87-3 |
C15H21NO3 |
 |
Linagliptin Impurity 51 |
|
|
 |
Carfilzomib Impurity YGF |
|
|
 |
5-Chloro-3-sulfino-2-thiophenecarboxylic acid |
187746-97-0 |
C5H3ClO4S2 |
![ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate](/CAS/20180703/GIF/431058-46-7.gif) |
ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate |
431058-46-7 |
C15H14FNO4 |
 |
Pitavastatin Impurity 45 |
1258947-29-3 |
C29H32FNO4 |
 |
Irinotecan Impurity L |
|
|
 |
Irinotecan Impurity H |
|
|
 |
LCZ696(valsartan + sacubitril) impurity 27 |
|
|
 |
Caspofungin Impurity EJT2 |
|
|
 |
Tofacitinib Impurity 100 |
|
|
 |
Vildagliptin Impurity 36 |
|
|
 |
Butyphthalide impurity 52 |
|
|
 |
Tofacitinib Impurity 102 |
1615709-90-4 |
C14H17ClN2 |
 |
Pralatrexate Impurity 12 |
1451250-74-0 |
C23H23N7O5 |
 |
Pralatrexate Impurity 17 |
|
|
 |
Pitavastatin Impurity 49 |
|
|
 |
Pitavastatin Impurity 55 |
|
|
 |
Lenvatinib Impurity 40 |
|
|
 |
Tazobactam Impurity 11 |
|
|
 |
Crisaborole Impurity 2 |
|
|
 |
Canagliflozin Impurity 58 |
|
|
 |
Canagliflozin Impurity 63 |
|
|
 |
Levetiracetam Impurity 23 |
|
|
 |
Selexipag Impurity 4 |
2928611-77-0 |
|
 |
Levosimendan Impurity 10 |
134678-47-0 |
C11H12N2O2 |
 |
methyl (Z)-3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C24H21N3O3 |
 |
Isavuconazole Impurity 11 |
2732924-99-9 |
C10H16ClN3O2 |
 |
Levosimendan Impurity 2 |
103416-88-2 |
C11H12N2O2 |
 |
Famotidine EP Impurity A |
88061-72-7 |
C8H15N7O2S3 |
 |
Meloxicam EP Impurity D |
1331636-17-9 |
C16H17N3O4S2 |
 |
Erythromycin Impurity |
40554-78-7 |
C37H65NO12 |
 |
Fluconazole EP Impurity I |
150168-54-0 |
C13H14BrF2N7O |
 |
1-benzyl-2-methyl-1H-imidazole-carbaldehyde |
39269-74-4 |
C12H12N2O |
 |
Tenofovir Related Compound 10 |
16958-60-4 |
C8H11N5O |
 |
N-(4-methyl-3-(N-(4-(pyridin-3-yl)pyrimidin-2-yl)acetamido)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide |
|
C31H33N7O2 |
 |
N1-benzyl-N1,4-dimethyl-N3-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine |
|
C24H23N5 |
 |
(E)-4-(((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3- yl)methyl)(methyl)amino)-4-oxobut-2-enoic acid |
|
C21H18FN3O5S |
 |
TROXACITABINE |
145511-98-4 |
C8H11N3O4 |
 |
XXZJUZXKBFUPQH-IKGGRYGDSA-N |
1618657-31-0 |
C18H17FO4 |
 |
6-methyl-2-oxo-5-pyridin-2-yl-1H-pyridine-3-carbonitrile |
106637-42-7 |
C12H9N3O |
 |
Cabozantinib impurity I |
|
|
 |
Rotigotine Impurity 2 |
|
|
 |
Rotigotine Impurity 9 |
|
|
 |
Olprinone Impurity 5 |
|
|
 |
Vitamin B5 Impurity 1 |
897045-90-8 |
C12H22N2O6 |
 |
Cilastatin Impurity 5 |
|
|
 |
(R)-3-(4-(2-chloro-5-iodobenzyl)phenoxy)tetrahydrofuran |
2194590-02-6 |
C17H16ClIO2 |
 |
Sitagliptin Impurity 69 |
2172430-88-3 |
C15H16F3NO4 |
 |
Trimetazidine Impurity 8 |
|
|
 |
MeropeneM iMpurity 5 |
|
|
 |
Perindopril IMpurity 6 |
2163775-15-1 |
C8H15NO4 |
![1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-(2-hydroxyethyl)-2,4-dimethyl-](/CAS/20210111/GIF/2170562-55-5.gif) |
1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-(2-hydroxyethyl)-2,4-dimethyl- |
2170562-55-5 |
C18H18FN3O3 |
 |
Levofloxacin Impurity 15 |
94714-58-6 |
C14H12F4O4 |
 |
Losartan Impurity 2 |
1407521-00-9 |
C22H20ClN3O |
 |
Epoxy Exemestane (6-Alfa Isomer) |
152764-24-4 |
C20H24O3 |
![6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridine](/CAS/20180601/GIF/1187966-94-4.gif) |
6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridine |
1187966-94-4 |
C20H16FN |
 |
2-methoxy-1,7,9-trimethylpurine-6,8-dione |
51168-26-4 |
C9H12N4O3 |
 |
2-クロロ-N-(2,5-ジメチルフェニル)アセトアミド |
5177-35-5 |
C10H12ClNO |
 |
(+/-)-tert-Butyl 6-Chloro-5-hydroxy-3-oxohexanoate |
319924-73-7 |
C10H17ClO4 |
 |
(R)-2-(2-aminothiazol-4-yl)-N-(2-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide |
1684452-80-9 |
C21H24N4O2S |
![1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-[2-[(3,3-ジフェニルプロピル)メチルアミノ]-1,1-ジメチルエチル]5-エチル](/CAS/20180703/GIF/210579-71-8.gif) |
1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-[2-[(3,3-ジフェニルプロピル)メチルアミノ]-1,1-ジメチルエチル]5-エチル |
210579-71-8 |
C37H44ClN3O6 |
 |
2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde |
2169267-53-0 |
C11H7ClFNO |
 |
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
2243785-99-9 |
C37H42F2N8O4 |
 |
5-(2-fluorophenyl)-N-methyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carboxamide |
2054536-04-6 |
C17H14FN3O3S |
 |
Ozagrel Impurity 10 |
|
|
 |
tris((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)amine |
|
C33H27F3N4 |
 |
Esmolol impurity C |
|
|
 |
(R)-(+)-(3-CHLORO-2-HYDROXYPROPYL)TRIMETHYLAMMONIUM CHLORIDE |
117604-42-9 |
C6H15Cl2NO |
 |
17-ヒドロキシ-21-(アセチルオキシ)プレグナ-4-エン-3,20-ジオン |
640-87-9 |
C23H32O5 |
 |
ビス(P-アセチルアミノフェニル)エーテル |
3070-86-8 |
C16H16N2O3 |
 |
3-(2-hydroxyethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
85677-95-8 |
C18H20N2O7 |
 |
3-isobutylisobenzofuran-1(3H)-one |
199736-94-2 |
C12H14O2 |
![isopropyl(4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]
pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate](/CAS/20200401/GIF/625115-54-0.gif) |
isopropyl(4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]
pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate |
625115-54-0 |
C22H23FN8O2 |
 |
(S)-Olodaterol |
868049-50-7 |
C21H26N2O5 |
 |
5,6-DIHYDRO-3-METHYLAMINO-2H-1,4-THIAZIN-2-ONE OXIME |
148639-72-9 |
C5H9N3OS |
 |
M-ISOBUTYL IBUPROFEN |
66622-47-7 |
C13H18O2 |
 |
1,3-ビス(メチルチオ)-2-プロパノール |
31805-83-1 |
C5H12OS2 |
 |
ニトロスカネイト |
19881-18-6 |
C13H8N2O3S |
 |
(R)-N-グリシジルフタルイミド |
181140-34-1 |
C11H9NO3 |
 |
6-chloro-N-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5- nitro-2-(propylthio)pyrimidin-4-amine |
1427523-93-0 |
C16H15ClF2N4O2S |
 |
Bendamustine Impurity 15 |
|
|
 |
Bendamustine Related Impurity 10 |
|
|
 |
Bortezomib Impurity 16 |
|
|
 |
Captopril Related Compound 8 |
112243-88-6 |
C9H15NO3S |
 |
Edoxaban Impurity 25 (1R,2S,4R) Oxalate |
|
|
 |
Ezetimibe Impurity 35 |
1650568-82-3 |
C39H46F2N2O5Si2 |